Sinopharm Group Co. Ltd (X2S) — Financial Flexibility Index
Sinopharm Group Co. Ltd (X2S) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-2.32 Billion (operating CF €-2.63 Billion minus capex €312.96 Million) represents 0% of total liabilities (€304.58 Billion). Check X2S cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinopharm Group Co. Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Sinopharm Group Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see Sinopharm Group Co. Ltd (X2S) cash flow conversion.
Annual Financial Flexibility Index for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Sinopharm Group Co. Ltd. Explore X2S debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | €15.76 Billion | €14.14 Billion | €256.20 Billion | ▲ +21.1% |
| 2024 | 0.05x | €13.51 Billion | €11.55 Billion | €266.14 Billion | ▼ -31.5% |
| 2023 | 0.07x | €19.51 Billion | €17.17 Billion | €263.08 Billion | ▼ -18.2% |
| 2022 | 0.09x | €23.09 Billion | €20.96 Billion | €254.71 Billion | ▲ +87.8% |
| 2021 | 0.05x | €11.38 Billion | €9.31 Billion | €235.76 Billion | ▼ -18.1% |
| 2020 | 0.06x | €13.05 Billion | €11.15 Billion | €221.29 Billion | ▼ -45.8% |
| 2019 | 0.11x | €20.98 Billion | €18.78 Billion | €192.95 Billion | ▲ +164.2% |
| 2018 | 0.04x | €6.89 Billion | €3.65 Billion | €167.50 Billion | ▼ -8.7% |
| 2017 | 0.05x | €5.33 Billion | €3.21 Billion | €118.27 Billion | ▼ -52.0% |
| 2016 | 0.09x | €10.62 Billion | €9.26 Billion | €113.18 Billion | ▼ -35.9% |
| 2015 | 0.15x | €14.43 Billion | €13.41 Billion | €98.55 Billion | ▲ +92.9% |
| 2014 | 0.08x | €7.01 Billion | €5.56 Billion | €92.37 Billion | ▼ -3.9% |
| 2013 | 0.08x | €6.07 Billion | €4.94 Billion | €76.84 Billion | — |